Deepti Behl

987 citations
30 papers · 618 · 1 hit paper · h-index 10

Impact in

  • Oncology top 10%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Cells and Metastasis
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Immune Cell Function and Interaction
    • Phagocytosis and Immune Regulation

Papers in

    • Lung Cancer Treatments and Mutations 5
    • Advanced Breast Cancer Therapies 3
    • Gastric Cancer Management and Outcomes 3
    • Colorectal Cancer Treatments and Studies 5
    • Cancer Immunotherapy and Biomarkers 4

Deepti Behl

27 papers receiving 610 citations

Deepti Behl's Hit Papers

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313 2019 · 253 citations
2530+2+4Years since publication50100150200250

Peers

Deepti Behl
Comparison fields: 5 of 62
  • Oncology 358
  • Immunology 144
  • Cancer Research 85
  • Hematology 52
  • Genetics 35
Replace Monika Csóka with:
Monika Csóka Hungary
P H de Mulder Netherlands
Tse-Ching Chen Taiwan
Katarína Macháleková Slovakia
Hengqi Zheng United States
Maria Pilar Andueza Spain
Markus Falk Germany
F Carnino Italy
A. M. Gianni Italy
Elizabeth Valentine United States
Deepti Behl relative to Monika Csóka Hungary Monika Csóka's profile →
Citations per field
00.5×1.5×
Monika Csóka · 1×
Citations per year

Countries citing papers authored by Deepti Behl

Since Specialization
Citations

This map shows the geographic impact of Deepti Behl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepti Behl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepti Behl more than expected).

Fields of papers citing papers by Deepti Behl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepti Behl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepti Behl. The network helps show where Deepti Behl may publish in the future.

Co-authors

The 25 scholars most cited alongside Deepti Behl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deepti Behl Line = papers co-authored together Deepti Behl links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313
Hit paper breakdown →
2019253
2 2005106
3 200751
4 200746
5 200929
6 201824
7 201017
8 201016
9 200716
10 200511
11 20227
12 20237
13 20236
14 20056
15 20085
16 20202
17 20242
18 20242
19 20232
20 20232

About Deepti Behl

Deepti Behl is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine, having authored 30 papers that have together received 618 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Advanced Breast Cancer Therapies (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Gastric Cancer Management and Outcomes (3 papers), Cancer Genomics and Diagnostics (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (358 citations), Immunology (144 citations), Cancer Research (85 citations), Hematology (52 citations) and Genetics (35 citations). Deepti Behl has collaborated with scholars based in United States. Frequent co-authors include E. Gabriela Chiorean, Tara Elisabeth Seery, Howard S. Höchster, Jaykumar Thumar, Ramesh K. Ramanathan, Sunil R. Hingorani, Katherine A. Guthrie, Anthony F. Shields, Shannon McDonough and Jeremy Kortmansky. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Mayo Clinic Proceedings and JCO Precision Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact